These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 18478580)
1. Alpha7 nicotinic acetylcholine receptor agonists: prediction of their binding affinity through a molecular mechanics Poisson-Boltzmann surface area approach. Grazioso G; Cavalli A; De Amici M; Recanatini M; De Micheli C J Comput Chem; 2008 Nov; 29(15):2593-602. PubMed ID: 18478580 [TBL] [Abstract][Full Text] [Related]
2. Design of novel alpha7-subtype-preferring nicotinic acetylcholine receptor agonists: application of docking and MM-PBSA computational approaches, synthetic and pharmacological studies. Grazioso G; Pomè DY; Matera C; Frigerio F; Pucci L; Gotti C; Dallanoce C; De Amici M Bioorg Med Chem Lett; 2009 Nov; 19(22):6353-7. PubMed ID: 19804970 [TBL] [Abstract][Full Text] [Related]
3. Insights into docking and scoring neuronal alpha4beta2 nicotinic receptor agonists using molecular dynamics simulations and QM/MM calculations. Sgrignani J; Bonaccini C; Grazioso G; Chioccioli M; Cavalli A; Gratteri P J Comput Chem; 2009 Nov; 30(15):2443-54. PubMed ID: 19360794 [TBL] [Abstract][Full Text] [Related]
4. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions. Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149 [TBL] [Abstract][Full Text] [Related]
5. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors. Ferrari AM; Degliesposti G; Sgobba M; Rastelli G Bioorg Med Chem; 2007 Dec; 15(24):7865-77. PubMed ID: 17870536 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes. Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687 [TBL] [Abstract][Full Text] [Related]
7. Octahydropyrrolo[3,4-c]pyrrole: a diamine scaffold for construction of either alpha4beta2 or alpha7-selective nicotinic acetylcholine receptor (nAChR) ligands. Substitutions that switch subtype selectivity. Bunnelle WH; Tietje KR; Frost JM; Peters D; Ji J; Li T; Scanio MJ; Shi L; Anderson DJ; Dyhring T; Grønlien JH; Ween H; Thorin-Hagene K; Meyer MD J Med Chem; 2009 Jul; 52(14):4126-41. PubMed ID: 19552432 [TBL] [Abstract][Full Text] [Related]
9. Modeling binding modes of alpha7 nicotinic acetylcholine receptor with ligands: the roles of Gln117 and other residues of the receptor in agonist binding. Huang X; Zheng F; Stokes C; Papke RL; Zhan CG J Med Chem; 2008 Oct; 51(20):6293-302. PubMed ID: 18826295 [TBL] [Abstract][Full Text] [Related]
10. Virtual screening for alpha7 nicotinic acetylcholine receptor for treatment of Alzheimer's disease. Chen SG; Gu RX; Dai H; Wei DQ J Mol Graph Model; 2013 Feb; 39():98-107. PubMed ID: 23261879 [TBL] [Abstract][Full Text] [Related]
11. Modeling differential binding of alpha4beta2 nicotinic acetylcholine receptor with agonists and antagonists. Huang X; Zheng F; Zhan CG J Am Chem Soc; 2008 Dec; 130(49):16691-6. PubMed ID: 19554732 [TBL] [Abstract][Full Text] [Related]